 Gene Expression Regulation, Developmental
"Gene Expression Regulation, Developmental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism.
| Descriptor ID |
D018507
|
| MeSH Number(s) |
G05.355.315.310
|
| Concept/Terms |
Gene Expression Regulation, Developmental- Gene Expression Regulation, Developmental
- Developmental Gene Expression Regulation
- Regulation of Gene Expression, Developmental
- Gene Expression Regulation, Embryologic
- Regulation, Gene Expression, Embryologic
- Embryologic Gene Expression Regulation
- Regulation of Gene Expression, Embryologic
- Regulation, Gene Expression, Developmental
|
Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Developmental".
Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Developmental".
This graph shows the total number of publications written about "Gene Expression Regulation, Developmental" by people in this website by year, and whether "Gene Expression Regulation, Developmental" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 | | 2002 | 1 | 5 | 6 | | 2003 | 2 | 2 | 4 | | 2004 | 0 | 2 | 2 | | 2006 | 2 | 4 | 6 | | 2007 | 5 | 3 | 8 | | 2008 | 2 | 2 | 4 | | 2009 | 1 | 2 | 3 | | 2010 | 0 | 3 | 3 | | 2011 | 3 | 0 | 3 | | 2012 | 1 | 1 | 2 | | 2013 | 2 | 3 | 5 | | 2014 | 0 | 1 | 1 | | 2015 | 0 | 1 | 1 | | 2016 | 1 | 1 | 2 | | 2017 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Gene Expression Regulation, Developmental" by people in Profiles.
-
Ishii S, Torii M, Son AI, Rajendraprasad M, Morozov YM, Kawasawa YI, Salzberg AC, Fujimoto M, Brennand K, Nakai A, Mezger V, Gage FH, Rakic P, Hashimoto-Torii K. Variations in brain defects result from cellular mosaicism in the activation of heat shock signalling. Nat Commun. 2017 05 02; 8:15157.
-
Lischinsky JE, Sokolowski K, Li P, Esumi S, Kamal Y, Goodrich M, Oboti L, Hammond TR, Krishnamoorthy M, Feldman D, Huntsman M, Liu J, Corbin JG. Embryonic transcription factor expression in mice predicts medial amygdala neuronal identity and sex-specific responses to innate behavioral cues. Elife. 2017 03 13; 6.
-
Sugrue KF, Zohn IE. Mechanism for generation of left isomerism in Ccdc40 mutant embryos. PLoS One. 2017; 12(2):e0171180.
-
Warrier S, Nuwayhid S, Sabatino JA, Sugrue KF, Zohn IE. Supt20 is required for development of the axial skeleton. Dev Biol. 2017 Jan 15; 421(2):245-257.
-
Dincman TA, Beare JE, Ohri SS, Gallo V, Hetman M, Whittemore SR. Histone deacetylase inhibition is cytotoxic to oligodendrocyte precursor cells in vitro and in vivo. Int J Dev Neurosci. 2016 Nov; 54:53-61.
-
Son AI, Hashimoto-Torii K, Rakic P, Levitt P, Torii M. EphA4 has distinct functionality from EphA7 in the corticothalamic system during mouse brain development. J Comp Neurol. 2016 07 01; 524(10):2080-92.
-
Caldovic L, Haskins N, Mumo A, Majumdar H, Pinter M, Tuchman M, Krufka A. Expression pattern and biochemical properties of zebrafish N-acetylglutamate synthase. PLoS One. 2014; 9(1):e85597.
-
Karpinski BA, Maynard TM, Fralish MS, Nuwayhid S, Zohn IE, Moody SA, LaMantia AS. Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome. Dis Model Mech. 2014 Feb; 7(2):245-57.
-
Murphy AJ, Pierce J, de Caestecker C, Libes J, Neblett D, de Caestecker M, Perantoni AO, Tanigawa S, Anderson JR, Dome JS, Das A, Carroll TJ, Lovvorn HN. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor. Pediatr Blood Cancer. 2014 Feb; 61(2):198-205.
-
Lim YH, Ovejero D, Sugarman JS, Deklotz CM, Maruri A, Eichenfield LF, Kelley PK, Jüppner H, Gottschalk M, Tifft CJ, Gafni RI, Boyce AM, Cowen EW, Bhattacharyya N, Guthrie LC, Gahl WA, Golas G, Loring EC, Overton JD, Mane SM, Lifton RP, Levy ML, Collins MT, Choate KA. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet. 2014 Jan 15; 23(2):397-407.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|